Annual D&A
$6.71 M
+$956.00 K+16.63%
December 1, 2024
Summary
- As of March 13, 2025, FDMT annual depreciation & amortization is $6.71 million, with the most recent change of +$956.00 thousand (+16.63%) on December 1, 2024.
- During the last 3 years, FDMT annual D&A has risen by +$3.69 million (+122.02%).
- FDMT annual D&A is now at all-time high.
Performance
FDMT Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$1.78 M
+$81.00 K+4.76%
December 1, 2024
Summary
- As of March 13, 2025, FDMT quarterly depreciation & amortization is $1.78 million, with the most recent change of +$81.00 thousand (+4.76%) on December 1, 2024.
- Over the past year, FDMT quarterly D&A has increased by +$160.00 thousand (+9.85%).
- FDMT quarterly D&A is now at all-time high.
Performance
FDMT Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$6.71 M
+$271.00 K+4.21%
December 1, 2024
Summary
- As of March 13, 2025, FDMT TTM depreciation & amortization is $6.71 million, with the most recent change of +$271.00 thousand (+4.21%) on December 1, 2024.
- Over the past year, FDMT TTM D&A has increased by +$578.00 thousand (+9.43%).
- FDMT TTM D&A is now at all-time high.
Performance
FDMT TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
FDMT Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.6% | +9.8% | +9.4% |
| 3 y3 years | +122.0% | +27.8% | +19.2% |
| 5 y5 years | +567.8% | +27.8% | +19.2% |
FDMT Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +122.0% | at high | +131.7% | at high | +122.0% |
| 5 y | 5-year | at high | +567.8% | at high | +418.6% | at high | +1849.1% |
| alltime | all time | at high | +971.1% | at high | +418.6% | at high | +1849.1% |
4D Molecular Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $6.71 M(+16.6%) | $1.78 M(+4.8%) | $6.71 M(+4.2%) |
| Sep 2024 | - | $1.70 M(+4.9%) | $6.43 M(+5.0%) |
| Jun 2024 | - | $1.62 M(+1.9%) | $6.13 M(+3.3%) |
| Mar 2024 | - | $1.59 M(+5.4%) | $5.93 M(+3.2%) |
| Dec 2023 | $5.75 M(+48.2%) | $1.51 M(+8.4%) | $5.75 M(+2.2%) |
| Sep 2023 | - | $1.40 M(-2.2%) | $5.62 M(+10.1%) |
| Jun 2023 | - | $1.43 M(+1.1%) | $5.11 M(+13.2%) |
| Mar 2023 | - | $1.41 M(+1.7%) | $4.51 M(+16.2%) |
| Dec 2022 | $3.88 M | $1.39 M(+57.9%) | $3.88 M(+18.9%) |
| Sep 2022 | - | $879.00 K(+5.8%) | $3.26 M(+3.8%) |
| Jun 2022 | - | $831.00 K(+6.3%) | $3.14 M(+2.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $782.00 K(+1.6%) | $3.05 M(+1.1%) |
| Dec 2021 | $3.02 M(+109.3%) | $770.00 K(+1.3%) | $3.02 M(+15.2%) |
| Sep 2021 | - | $760.00 K(+2.4%) | $2.62 M(+17.5%) |
| Jun 2021 | - | $742.00 K(-0.8%) | $2.23 M(+20.7%) |
| Mar 2021 | - | $748.00 K(+101.6%) | $1.85 M(+28.0%) |
| Dec 2020 | $1.44 M(+43.7%) | $371.00 K(+0.5%) | $1.44 M(+34.6%) |
| Sep 2020 | - | $369.00 K(+2.8%) | $1.07 M(+52.5%) |
| Jun 2020 | - | $359.00 K(+4.4%) | $703.00 K(+104.4%) |
| Mar 2020 | - | $344.00 K | $344.00 K |
| Dec 2019 | $1.00 M(+44.0%) | - | - |
| Dec 2018 | $697.00 K(+11.3%) | - | - |
| Dec 2017 | $626.00 K | - | - |
FAQ
- What is 4D Molecular Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics annual D&A year-on-year change?
- What is 4D Molecular Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics quarterly D&A year-on-year change?
- What is 4D Molecular Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics TTM D&A year-on-year change?
What is 4D Molecular Therapeutics annual depreciation & amortization?
The current annual D&A of FDMT is $6.71 M
What is the all time high annual D&A for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high annual depreciation & amortization is $6.71 M
What is 4D Molecular Therapeutics annual D&A year-on-year change?
Over the past year, FDMT annual depreciation & amortization has changed by +$956.00 K (+16.63%)
What is 4D Molecular Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of FDMT is $1.78 M
What is the all time high quarterly D&A for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high quarterly depreciation & amortization is $1.78 M
What is 4D Molecular Therapeutics quarterly D&A year-on-year change?
Over the past year, FDMT quarterly depreciation & amortization has changed by +$160.00 K (+9.85%)
What is 4D Molecular Therapeutics TTM depreciation & amortization?
The current TTM D&A of FDMT is $6.71 M
What is the all time high TTM D&A for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high TTM depreciation & amortization is $6.71 M
What is 4D Molecular Therapeutics TTM D&A year-on-year change?
Over the past year, FDMT TTM depreciation & amortization has changed by +$578.00 K (+9.43%)